Obesity
📧 Sign up to get email alerts when something new happens for Obesity.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: A Mobile Intervention to Reduce Pain and Improve Health (MORPH) [NA]
A completed clinical trial evaluating a mobile intervention (MORPH) aimed at reducing pain and improving health in individuals with chronic …
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: A Study Comparing the Injection Site Pain Experience After the Injection of Semaglutide B and Semaglutide D With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity [Phase 2]
Phase 2 study comparing injection site pain for semaglutide B versus semaglutide D using two different pens in adults, including healthy vol…
-
CLINICAL_TRIALS trial_result · 2021-01-15Clinical Trial Update: A Study to Evaluate the Effect of MEDI0382 on Energy Balance in Overweight and Obese Participants With Type 2 Diabetes Mellitus [Phase 2]
Phase 2 trial evaluating MEDI0382 for energy balance in overweight/obese individuals with type 2 diabetes completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-01-08Clinical Trial Update: Family Empowerment for Enhanced Development [NA]
A completed clinical trial from University of Pittsburgh focusing on obesity and feeding behavior in children; results posted in 2021.
-
FDA approval · 2021-01-06FDA Approved: BENZPHETAMINE HYDROCHLORIDE — Supplemental Application (Epic Pharma, LLC)
The FDA approved a supplemental application for benzphetamine hydrochloride developed by Epic Pharma, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-01-06Clinical Trial Update: Effect of LIK066 on Reduction of Fatty Content in Livers of Obese Patients [Phase 2]
Phase 2 trial assessing LIK066 for reducing fatty content in livers of obese patients with non-alcoholic steatohepatitis (NASH); study compl…
-
FDA approval · 2021-01-05FDA Approved: BENZPHETAMINE HYDROCHLORIDE — Supplemental Application (KVK-TECH, INC)
FDA approved a supplemental application for benzphetamine hydrochloride from KVK-Tech, Inc. This action confirms the drug's regulatory appro…
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: Opt-IN: Optimization of Remotely Delivered Intensive Lifestyle Treatment for Obesity [Phase 2, Phase 3]
Clinical trial update for Opt-IN: Optimization of Remotely Delivered Intensive Lifestyle Treatment for Obesity reports completed phases 2 an…
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: FitLink: Improving Weight Loss Maintenance by Using Digital Data to Provide Support and Accountability [NA]
A completed clinical trial evaluating FitLink for weight loss maintenance using digital data to provide support and accountability.
-
CLINICAL_TRIALS trial_result · 2020-12-31Clinical Trial Update: Healthy Body Healthy Souls in the Marshallese Population [NA]
Completed clinical trial in Marshallese population on weight loss and pre-diabetes; results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-30Clinical Trial Update: Effect of Oligofructose on Appetite in Overweight Subjects [NA]
A completed clinical trial studying the effect of oligofructose on appetite in overweight individuals, with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-29Clinical Trial Update: Weight Loss in Chronic Disease Patient Population [NA]
Completed clinical trial investigating weight loss in overweight and obese adults, with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: Study of the Gut Hormone Analogue G3215 in Adult Subjects [Phase 1]
Phase 1 clinical trial update for the gut hormone analogue G3215 in adults with diabetes mellitus and obesity; results posted after completi…
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: Apixaban Pharmacokinetics in Bariatric Patients (APB) [Phase 4]
Phase 4 clinical trial update on apixaban pharmacokinetics in bariatric patients completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: Weight Loss Benefits of Rifaximin in an Intermittent Fasting Diet [Phase 4]
Phase 4 clinical trial investigating weight loss benefits of rifaximin under an intermittent fasting diet; status currently UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Effects of Intermittent Hypoxia (IH) on Metabolism and Dysglycemia, in Overweight/Obese Persons SCI [NA]
Clinical trial update on effects of intermittent hypoxia on metabolism and dysglycemia in overweight/obese individuals with spinal cord inju…
-
CLINICAL_TRIALS trial_result · 2020-12-10Clinical Trial Update: Promoting Successful Weight Loss in Primary Care in Louisiana [NA]
Clinical trial on promoting successful weight loss in primary care in Louisiana has completed and posted results.
-
FDA approval · 2020-12-04FDA Approved: SAXENDA — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for SAXENDA (liraglutide) from Novo Nordisk.
-
CLINICAL_TRIALS trial_result · 2020-12-01Clinical Trial Update: Anidulafungin Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (ADOPT) [Phase 4]
Phase 4 trial updating pharmacokinetics of anidulafungin given as a single IV dose in obese patients.
-
CLINICAL_TRIALS trial_result · 2020-12-01Clinical Trial Update: Effect of Obesity on Immune Response to Pneumovax 23
Clinical trial assessing how obesity affects the immune response to Pneumovax 23 has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-30Clinical Trial Update: Effect of Bile Acids and Bile Acid Sequstrants on GLP-1 Secretion After Roux-en-Y Gastric Bypass [Phase 4]
Phase 4 trial evaluating the effect of bile acids and bile acid sequestrants on GLP-1 secretion after Roux-en-Y gastric bypass in individual…
-
CLINICAL_TRIALS trial_result · 2020-11-30Clinical Trial Update: Effects of Bile Acids and Bile Acid Sequestrants on GLP-1 Secretion After Roux-en-Y Gastric Bypass [Phase 4]
Phase 4 clinical trial investigating how bile acids and bile acid sequestrants affect GLP-1 secretion after Roux-en-Y gastric bypass in adul…
-
CLINICAL_TRIALS research · 2020-11-27Clinical Trial Update: Drug Concentration Analysis of Micafungin in Overweight, Obese, and Extremely Obese Volunteers [Phase 4]
Phase 4 trial analyzing micafungin pharmacokinetics across overweight and obese volunteers; results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-24Clinical Trial Update: Synbiotic Therapy on Intestinal Microbiota and Insulin Resistance in Obesity [Phase 4]
Phase 4 trial update on synbiotic therapy assessing effects on intestinal microbiota and insulin resistance in obesity.
-
CLINICAL_TRIALS trial_result · 2020-11-19Clinical Trial Update: The Odense Overweight Intervention Study [NA]
Trial update for the Odense Overweight Intervention Study with unknown status; results posted in 2020, targeting overweight children.